Vector-mediated cancer gene therapy: an overview

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Significant advancements in understanding cancer's molecular basis have fueled gene therapy development.
• The creation of effective DNA delivery systems (vectors) is crucial for gene therapy applications.

Purpose of the Study:

• To review diverse cancer gene therapy strategies.
• To examine various viral and non-viral vectors used for gene delivery in cancer treatment.

Main Methods:

• Review of established and emerging gene therapy approaches.
• Analysis of commonly employed viral vectors (retroviral, adenoviral, AAV, pox, herpes simplex, HIV-based) and non-viral vectors.
• Discussion of targetable vectors for enhanced specificity.

Main Results:

• Comprehensive overview of strategies including tumor suppressor gene transfer, suicide gene therapy, oncogene inhibition, immunomodulation, and modulation of angiogenesis, invasion, and metastasis.
• Detailed examination of vector systems for delivering therapeutic genes.
• Exploration of chemosensitization, radiosensitization, and stem cell chemoprotection approaches.

Conclusions:

• Cancer gene therapy presents a promising frontier with multiple strategic avenues.
• The choice of vector significantly impacts therapeutic efficacy and safety.
• Ongoing research into challenges and future directions is vital for clinical translation.